Cerulean Pharma reported $-9163000 in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agile Therapeutics AGRX:US $ -17.64M 0.51M
Arrowhead Research ARWR:US $ -29.92M 3.11M
Bayer BAYN:GR € 1537M 1825M
Biocept BIOC:US $ -1.83M 4.43M
Brainstorm Cell Therapeutics BCLI:US $ -6.27M 0.39M
Cerulean Pharma CERU:US $ -9.16M 1.84M
Immunogen IMGN:US $ -30.74M 3.31M
Johnson & Johnson JNJ:US $ 7776M 515M
Macrogenics MGNX:US $ -39.94M 11.34M
Nektar Therapeutics NKTR:US $ -125.16M 3.89M
YTE INCY:US $ 199.6M 31.06M